Emerging studies suggest Retatru tide , a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may provide a promising step forward for weight loss . Early human tests https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026